EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The EAHP staff supports the Board in executing EAHP’s mission. The Staff assists in financial management, events organisations, policy activities and all EAHP projects. The EAHP staff works closely with EAHP’s members and ensures the effective communication all relevant stakeholders.
The first member countries were Belgium, Britain, Denmark, France, the Federal Republic of Germany and The Netherlands in 1972. EAHP has now 36 EAHP members and 2 Associate Members. EAHP is open to countries members of the Council of Europe and since 2022 to organisations representing the interests of hospital pharmacists from outside the Council of Europe (Associate Membership)
EAHP’s structure is also composed by different standing committes: EAHP Scientific Committee, EAHP Education Executive Committee and the EAHP CTF Steering Committee.
At EAHP, we are committed to transparency in our governance, ethical standards, and funding practices. This section provides open access to our foundational documents, including the EAHP Statutes, Code of Conduct, and Funding Sources. By sharing these resources, we aim to uphold accountability and foster trust with our members, partners, and the public.
Keep up with all EAHP’s events and webinars. Contact the team at info@eahp.eu should you have any questions about upcoming events or activities.
Here you can find all upcoming events organised by EAHP and by all its members and associate members. Do not hesitate to contact the events team at events@eahp.eu should you have any questions about the organisation of these events.
Hospital pharmacists conduct a critical role in the care of patients in hospitals. Learn more about what they do here and in all the pages under Hospital Pharmacy practice and Policy.
Self-Assessment
SILCC
Closed SIGs
EAHP brings together experts from many areas of hospital pharmacy practice providing and highlighting good local sustainable practices as that can be up-scaled and shared with other countries. The EAHP Working Group on Sustainability has the aim of reducing the environmental burden of the hospital pharmacy services.
The European Association of Hospital Pharmacists (EAHP), and its 36 member country platforms are creating a Common Training Framework for the hospital pharmacy education in Europe. The goal of this project is to allow the free movement of hospital pharmacists within the European Union.
The European Association of Hospital Pharmacists (EAHP) and the European Society of Clinical Pharmacy (ESCP) have collaboratively developed the Oath to Society. The Oath to Society is all encompassing and acts as a contract for excellence in providing compassionate patient care, working as part of the healthcare team and advancing the pharmacy profession, and showcasing how clinical and hospital pharmacists work every day
A day created to highlight the importance and to celebrate the work done by hospital pharmacies. This day celebrates all hospital pharmacy teams.
Catch up with EAHP’s press releases
Find all EAHP relevant publication like the EAHP Surveys, annual reports and the history books.
The European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients.
When EAHP and Hospital pharmacists appear in the news.
EAHP publishes a monthly EU monitor with updates about the latest EAHP initiatives and information relevant for the hospital pharmacy profession.
Sponsor Channel
The Sponsor Channel is designed to maximise visibility and engagement, allowing sponsors to connect with the hospital pharmacy community and partners in a dynamic and interactive environment. From product demonstrations to networking sessions, the Sponsor Channel offers a range of opportunities for sponsors to showcase their offerings and generate leads in the new EAHP Website.
EAHP announces the launch of its new website! The new platform offers an improved user experience, new design, enhanced navigation, and a lot of updated content. Whether you’re looking for the latest news, resources, or our upcoming events, you’ll find everything you need. Explore the new site and discover how we are continuing to support and advance the profession of hospital pharmacy!
Visit the new website here: https://eahp.eu
The Abstract & GPI poster exhibition and the oral poster communication sessions are the mainstay of the annual EAHP Congress and only the best are selected!
The EAHP Scientific Committee (SC) encourages all hospital pharmacists, other health care professionals and scientists to submit their work for consideration leading to possible acceptance and display at the 29th EAHP Congress.
The SC strives to receive submissions of hospital pharmacy related initiatives from applicants in Europe and all over the world.”
Deadline for abstracts: 09 October 2024 (23h59 CEST)
EAHP BOOST: “Humanizing the High-Tech Pharmacy” took place on 27-28 September 2024, focusing on the synergy between advanced automation and the irreplaceable human element in hospital pharmacy. The event opened with a keynote on “Management Perspective on Automation”, followed by two seminar tracks—one focused on automation in medicine reconstitution and production, highlighting the role of robots in Total Parenteral Nutrition (TPN) and cytotoxic preparation, and the other on patient-centered care with automated bedside dispensing and AI in pharmaceutical care. With interactive ‘world café’ workshops tailored to different expertise levels, the event highlighted how automation can boost operational efficiency while preserving the vital human touch in patient care.
The European Association of Hospital Pharmacists (EAHP) is pleased to announce that registrations to the third Synergy Masterclass are open! Titled “Strategy and Leadership Perspectives for Digital Transformation of Hospital Pharmacies,” will take place on 29 and 30 November 2024 in Brussels, supported by an educational grant from BD. This masterclass is part of the expanded Synergy programme, which aims to provide continuing education and advance the hospital pharmacy profession globally. Accredited by the European Commission of Pharmacy Associations (ECPhA), the Synergy Masterclasses address ground-breaking topics essential for hospital pharmacists and healthcare professionals, functioning as one- or two-day mini congresses that promote in-depth discussions and knowledge sharing.
You can register here
On the occasion of the II United Nations General Assembly High-Level Meeting on Antimicrobial Resistance (AMR), EAHP joined the European Network for Infection Prevention and Antimicrobial Resistance (ENIPAR) with the aim to call on the importance to prevent and fight against AMR and to recommend a series of measures for achieving these objectives.
Please find the call to action HERE
The European Court of Auditors (ECA) has completed its first comprehensive audit of the European Centre for Disease Prevention and Control (ECDC) and the European Medicines Agency (EMA) during the COVID-19 pandemic. The reporthighlights that both agencies generally responded well but were not fully prepared for a prolonged health crisis. Key recommendations include improving internal procedures at ECDC and EMA, enhancing coordination with the newly established Health Emergency Preparedness and Response Authority (HERA), and clarifying the roles of these institutions in future health emergencies.
The European Commission released a guidance document on the validity of clinical studies for joint clinical assessments under the EU HTA Regulation.
This guidance aims to provide a framework for defining, classifying, and assessing the certainty of clinical study results in an objective, transparent, and reproducible manner. It addresses the analysis of data from various types of individual clinical studies.
The European Medicines Agency (EMA) has introduced a new pilot programme to aid the development and assessment of orphan medical devices in the EU. The initiative offers free advice from expert panels to manufacturers and notified bodies on the orphan status and clinical evaluation of these devices. The programme, running until the end of 2025, aims to establish a long-term support process for devices used in rare diseases or conditions. Priority will be given to life-threatening conditions, devices for children, and novel technologies with significant clinical potential. The programme follows new EU legislation and guidance on orphan device classification.
The European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) have published high-level principles and recommendations on the use of large language models (LLMs) within the European medicines regulatory network (EMRN). LLMs, a form of generative AI, have the potential to transform regulatory tasks, from data mining to administrative automation. However, they also pose risks such as inaccurate outputs and data security concerns. The guidelines aim to help regulators use LLMs effectively, covering safe data handling, critical analysis, and ongoing staff training. The principles are part of a broader AI workplan running until 2028.
The European Commission is considering allowing the use of electronic instructions for use (eIFUs) for all professional use devices and has launched a public consultation targeted at healthcare professionals.
The deadline for the consultation is 11 October 2024 and can be accessed HERE.
Supporting the “Joint Action on Personalized Cancer Medicine”, the initiative focuses on developing best practices, public health guidelines, and innovative approaches for cancer diagnostics and treatment, including genomic testing and metastatic cancer management. It also aims to reduce health inequalities by supporting training, capacity building, and patient consultations. This call aligns with Europe’s Beating Cancer Plan and other key EU health initiatives, aiming to improve cancer care and patient outcomes across Member States.
The deadline for submitting the proposals is 22 January 2025, 17:00 (CET).
The call aims to pilot best practices for population-level interventions, develop guidelines for preventing and controlling NCDs, reduce exposure to second-hand smoke and emerging tobacco products, and target vulnerable groups such as children, young people, and the elderly.
The deadline for submitting the proposals is 22 January 2025, 17:00 (CET).
The project focuses on building expert communities, developing guidelines, and testing AI deployment in real-life medical environments. Key areas include cancer treatment and addressing healthcare challenges in remote areas. The initiative also aims to educate healthcare professionals, patients, and policymakers, while fostering collaboration through a digital tool for sharing best practices. One project will be funded under this call to support the broader adoption of AI in healthcare.
The deadline for submitting the proposals is 22 January 2025, 17:00 (CET).
